Klingenstein Fields & CO LP Eli Lilly & CO Transaction History
Klingenstein Fields & CO LP
- $2.32 Billion
- Q1 2025
A detailed history of Klingenstein Fields & CO LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Klingenstein Fields & CO LP holds 101,555 shares of LLY stock, worth $77.8 Million. This represents 3.62% of its overall portfolio holdings.
Number of Shares
101,555
Previous 102,797
1.21%
Holding current value
$77.8 Million
Previous $79.4 Million
5.69%
% of portfolio
3.62%
Previous 3.24%
Shares
29 transactions
Others Institutions Holding LLY
# of Institutions
4,393Shares Held
821MCall Options Held
10MPut Options Held
10.8M-
Pnc Financial Services Group, Inc. Pittsburgh, PA101MShares$77.6 Billion44.13% of portfolio
-
Lilly Endowment Inc Indianapolis, IN96MShares$73.5 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA79.2MShares$60.7 Billion1.22% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$50.4 Billion1.37% of portfolio
-
State Street Corp Boston, MA34.4MShares$26.4 Billion1.2% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $728B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...